Results 151 to 160 of about 4,164 (194)

Early transition from short-term romosozumab to antiresorptive therapies: analysis of 26 cases. [PDF]

Arch Osteoporos
Everts-Graber J, Ferrari S, Popp A, Hars M, Wenger M, Oser S, Studer U, Steiner C, Ziswiler HR, Schmid G, Reichenbach S, Lehmann T, Lamy O, Gonzalez-Rodriguez E.   +13 more
europepmc   +1 more source

A Case of Early-Onset Osteoporosis Due to a Novel WNT1 Variant. [PDF]

AACE Endocrinol Diabetes
Bailey R, Gee C, Schoenhoff G, Dai-Ju JQ.   +3 more
europepmc   +1 more source

Drugs against osteoporosis in perimenopausal and postmenopausal women. [PDF]

Front Med (Lausanne)
Lv H, Zhang Y, Li J, Jia Q, Yu Y, Tang H, Chen W, Yang Y, Jiang Q, Chen J.   +9 more
europepmc   +1 more source

Effective management of pregnancy- and lactation-associated osteoporosis using romosozumab: a clinical case report. [PDF]

JBMR Plus
Goshima A, Tsuboi H, Kaito T, Iwasaki M.
europepmc   +1 more source

Real-world evidence indicates romosozumab use is associated with a greater reduction in osteoporotic fractures than PTH (1-34) analogs in women. [PDF]

Biol Sex Differ
Lu KH, Wang SI, Yang SF.
europepmc   +1 more source

Severe early-onset osteoporosis due to heterozygous WNT1 variants in adults: a clinical and therapeutic challenge. [PDF]

J Bone Miner Res
Ryhänen EM, Mäkitie RE, Pekkarinen T, Kröger H, Tong X, Kerttula L, Mäkitie O, Schalin-Jäntti C.   +7 more
europepmc   +1 more source

Sclerostin deficiency sensitizes white adipocytes to thermogenic signals that induce beiging in mice. [PDF]

Nat Commun
Choquette GM, Kim SP, Wilkinson KJ, Avelar BC, Pathy S, Li Z, Wu J, Aja S, Thorek DLJ, Wolfgang MJ, Riddle RC.   +10 more
europepmc   +1 more source

Romosozumab Improves Tissue Thickness-Adjusted Trabecular Bone Score in Women With Osteoporosis and Diabetes.

J Clin Endocrinol Metab
Ferrari S, Betah D, Feldman RG, Langdahl BL, Oates M, Timoshanko J, Wang Z, Dhaliwal R.   +7 more
europepmc   +1 more source

Romosozumab significantly improves vertebral cortical bone mass and structure compared with teriparatide, whereas both treatments increase vertebral trabecular bone mass similarly: high-resolution quantitative computed tomography analyses of randomized controlled trial results in postmenopausal women with low bone mineral density. [PDF]

JBMR Plus
Damm T, Libanati C, Peña J, Hanley DA, Bolognese MA, Recknor C, Glüer CC.   +6 more
europepmc   +1 more source

Brazilian guidelines for the management of osteoporosis in diabetes mellitus. [PDF]

Diabetol Metab Syndr
de Paula FJA, Silva BCC, D Alva CB, Ohe MN, Madeira M, E Farias LB, de Holanda NCP, Gomes ND, da Silva Filho RL, Lauria MW, Bertoluci MC.   +10 more
europepmc   +1 more source